{"id":2518,"date":"2018-02-28T16:57:00","date_gmt":"2018-02-28T16:57:00","guid":{"rendered":"http:\/\/staging.grindeks.eu\/turnover-of-grindeks-reaches-132-4-million-euro-in-2017-profit-10-3-million-euro\/"},"modified":"2022-07-04T17:00:04","modified_gmt":"2022-07-04T17:00:04","slug":"turnover-of-grindeks-reaches-132-4-million-euro-in-2017-profit-10-3-million-euro","status":"publish","type":"post","link":"https:\/\/grindeks.com\/lv\/turnover-of-grindeks-reaches-132-4-million-euro-in-2017-profit-10-3-million-euro\/","title":{"rendered":"2017. gad\u0101 Grindeks sasniedz 132,4 milj. eiro apgroz\u012bjumu un 10,3 milj. eiro pe\u013c\u0146u"},"content":{"rendered":"\n

\u0160odien, 28. febru\u0101r\u012b, akciju sabiedr\u012bbas Grindeks Nasdaq Riga iesniegtie 2017. gada nerevid\u0113tie konsolid\u0113tie finan\u0161u p\u0101rskati liecina, ka koncerna apgroz\u012bjums 2017. gad\u0101 bija 132,4 milj. eiro, kas ir par 27 milj. eiro vai par 26% vair\u0101k nek\u0101 2016. gad\u0101. Savuk\u0101rt koncerna neto pe\u013c\u0146a, kas attiecin\u0101ma uz m\u0101tes sabiedr\u012bbas akcion\u0101riem, 2017. gad\u0101 bija 10,3 milj. eiro, kas, sal\u012bdzinot ar 2016. gadu, ir palielin\u0101jusies par 0,8 milj. eiro vai 8%.<\/p>\n\n\n\n

Bruto pe\u013c\u0146as rentabilit\u0101te 2017. gad\u0101 bija 57%, savuk\u0101rt t\u012br\u0101s pe\u013c\u0146as rentabilit\u0101te bija 8%. 2017. gad\u0101 koncerna sara\u017eot\u0101 produkcija eksport\u0113ta uz 77 pasaules valst\u012bm kopum\u0101 par 122,4 milj. eiro, kas ir par 27,2 milj. eiro vai par 28% vair\u0101k nek\u0101 2016. gad\u0101.<\/p>\n\n\n\n

P\u0101rskata perioda beig\u0101s debitoru par\u0101du apjoms veidoja 63,7 milj. eiro, kas ir par 22,4 milj. eiro vair\u0101k nek\u0101 kreditoru apjoms, kas veidoja 41,3 milj. eiro. Apgroz\u0101mo l\u012bdzek\u013cu apjoms p\u0101rskata perioda beig\u0101s bija 92,2 milj. eiro, kas par 67,1 milj. eiro p\u0101rsniedza \u012bstermi\u0146a kreditoru apjomu, kas bija 25,1 milj. eiro.<\/p>\n\n\n\n

AS Grindeks valdes priek\u0161s\u0113d\u0113t\u0101js Juris Bundulis<\/a>: \u201eDinamiskais k\u0101pums apliecina, ka Grindeks ir uz veiksm\u012bgi izv\u0113l\u0113ta un stabila strat\u0113\u0123isk\u0101s att\u012bst\u012bbas kursa. Tam pamat\u0101 ir poz\u012bciju nostiprin\u0101\u0161ana eso\u0161ajos tirgos un sekm\u012bga darb\u012bbas papla\u0161in\u0101\u0161ana jaunos re\u0123ionos. 2018. gad\u0101 l\u012bdztekus tradicion\u0101lajiem noieta tirgiem esam motiv\u0113ti turpin\u0101t biznesa att\u012bst\u012bbu Eiropas Savien\u012bbas valst\u012bs, kur jau 2017. gad\u0101 koncerna apgroz\u012bjums sasniedza teju 20 miljonus eiro, k\u0101 ar\u012b turpin\u0101sim ies\u0101kto Dienvidaustrum\u0101zijas tirgu apguvi.\u201d<\/p>\n\n\n\n

Grindeks gatavo z\u0101\u013cu p\u0101rdo\u0161anas apjoms 2017. gad\u0101 bija 124,2 milj. eiro un ir palielin\u0101jies, sal\u012bdzinot ar 2016. gadu, par 27,2 milj. eiro vai 28%. P\u0101rdo\u0161anas apjoms Krievij\u0101, p\u0101r\u0113j\u0101s NVS valst\u012bs un Gruzij\u0101 2017. gad\u0101 sasniedza 81,1 milj. eiro, kas ir par 23 milj. eiro vai par 39% vair\u0101k nek\u0101 2016. gad\u0101. Sal\u012bdzinot ar 2016. gadu, 2017. gad\u0101, iev\u0113rojam\u0101kais p\u0101rdo\u0161anas apjoma pieaugums sasniegts \u2013 Tad\u017eikist\u0101n\u0101 par 69%, Krievij\u0101 par 53%, Ukrain\u0101 par 40%, Arm\u0113nij\u0101 par 35%, Azerbaid\u017e\u0101n\u0101 par 34%, un Kirgizst\u0101n\u0101 par 34%.<\/p>\n\n\n\n

P\u0101rdo\u0161anas apjoms Baltijas un cit\u0101s valst\u012bs 2017. gad\u0101 sasniedza 43,1 milj. eiro, kas ir par 4,2 milj. eiro vai 11% vair\u0101k nek\u0101 2016. gad\u0101. P\u0101rdo\u0161anas apjoms 2017. gad\u0101, sal\u012bdzinot ar 2016. gadu, ir palielin\u0101jies Slov\u0101kij\u0101 4,3 reizes, Austr\u0101lij\u0101 3,6 reizes, Alb\u0101nij\u0101 par 93%, Francij\u0101 par 90%, Sp\u0101nij\u0101 par 63%, Zviedrij\u0101 par 60%. P\u0101rdo\u0161anas apjoms Latvij\u0101 2017. gad\u0101 sasniedza 7,4 milj. eiro, un, sal\u012bdzinot ar 2016. gadu, pieauga par 0,1 milj. eiro vai par 2%. Pieaugumi ir ar\u012b p\u0101r\u0113j\u0101s div\u0101s Baltijas valst\u012bs \u2013 Lietuv\u0101 par 13% un Igaunij\u0101 par 6%.<\/p>\n\n\n\n

2017. gad\u0101 akt\u012bvo farmaceitisko vielu p\u0101rdo\u0161anas apjoms sasniedza 6,9 milj. eiro, kas ir par 0,6 milj. eiro vai 9% vair\u0101k nek\u0101 2016. gad\u0101. \u0160aj\u0101 period\u0101 liel\u0101kais Grindeks akt\u012bvo farmaceitisko vielu eksports tika veikts uz ES valst\u012bm, Kan\u0101du, Austr\u0101liju un Jap\u0101nu. Grindeks piepras\u012bt\u0101k\u0101s akt\u012bv\u0101s farmaceitisk\u0101s vielas 2017. gad\u0101 bija zopiklons, oksitoc\u012bns, pimobend\u0101ns, medetomid\u012bns, ftoraf\u016brs, un ksilaz\u012bns.<\/p>\n\n\n\n

AS Grindeks padomes priek\u0161s\u0113d\u0113t\u0101js Kirovs Lipmans<\/a>: \u201eGrindeks akcion\u0101ru skat\u012bjum\u0101 uz\u0146\u0113mums 2017. gad\u0101 ir sasniedzis augstus rezult\u0101tus. \u012apa\u0161i v\u0113los izcelt iev\u0113rojamo koncerna v\u0113rt\u012bbas pieaugumu, uzlabojumus kop\u0113j\u0101 finan\u0161u pl\u016bsm\u0101 un b\u016btisko debitoru par\u0101du samazin\u0101jumu. 2018. gad\u0101 turpin\u0101m sagaid\u012bt stabilu uz\u0146\u0113muma izaugsmi un vismaz 10% apgroz\u012bjuma k\u0101pumu. \u0160ogad augo\u0161\u0101 piepras\u012bjuma nodro\u0161in\u0101\u0161anai palielin\u0101sim ra\u017eo\u0161anas jaudas koncerna ra\u017eotn\u0113s Latvij\u0101, Igaunij\u0101 un Slov\u0101kij\u0101, invest\u0113jot vismaz 7 miljonus eiro. Uz\u0146\u0113muma padomes un akcion\u0101ru v\u0101rd\u0101 veltu pateic\u012bbu Grindeks komandai par pag\u0101ju\u0161\u0101 gada sniegumu\u201d.<\/p>\n","protected":false},"excerpt":{"rendered":"

\u0160odien, 28. febru\u0101r\u012b, akciju sabiedr\u012bbas Grindeks Nasdaq Riga iesniegtie 2017. gada nerevid\u0113tie konsolid\u0113tie finan\u0161u p\u0101rskati liecina, ka koncerna apgroz\u012bjums 2017. gad\u0101 bija 132,4 milj. eiro,…<\/p>\n","protected":false},"author":3,"featured_media":2468,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-2518","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-jaunums"],"acf":[],"_links":{"self":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts\/2518","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/comments?post=2518"}],"version-history":[{"count":0,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts\/2518\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media\/2468"}],"wp:attachment":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media?parent=2518"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/categories?post=2518"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/tags?post=2518"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}